ECVT Stock Analysis: Ecovyst | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 1.363m USD | 12M Return: 36.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.1M
EPS Trend: -64.1%
Qual. Beats: 3
Rev. Trend: 44.5%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ecovyst Inc. (NYSE: ECVT) is a specialty chemicals company that produces and sells both virgin and regenerated sulfuric acid, serving customers in the United States and international markets. Its products and logistics services support alkylate production for refineries, as well as mining, water treatment, and broader industrial applications. Sulfuric acid is one of the most widely consumed industrial chemicals globally, and Ecovysts regeneration capabilities position it within the circular economy by reclaiming and reprocessing spent acid rather than producing only new material. The company was originally founded in 1831 as PQ Group Holdings and rebranded as Ecovyst in August 2021; it is headquartered in Wayne, Pennsylvania, and is classified within the GICS Materials sector.
- Refinery utilization drives virgin sulfuric acid demand
- Mining sector consumption supports acid pricing
- Catalyst Technologies margins expand on higher utilization
| Net Income: -63.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.28 > 1.0 |
| NWC/Revenue: 21.53% < 20% (prev 27.35%; Δ -5.83% < -1%) |
| CFO/TA 0.12 > 3% & CFO 147.0m > Net Income -63.2m |
| Net Debt (283.8m) to EBITDA (151.7m): 1.87 < 3 |
| Current Ratio: 2.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (111.8m) vs 12m ago -4.67% < -2% |
| Gross Margin: 21.99% > 18% (prev 26.09%; Δ -4.11% > 0.5%) |
| Asset Turnover: 54.02% > 50% (prev 38.45%; Δ 15.57% > 0%) |
| Interest Coverage Ratio: 2.56 > 6 (EBIT TTM 75.7m / Interest Expense TTM 29.6m) |
| A: 0.14 (Total Current Assets 304.3m - Total Current Liabilities 127.9m) / Total Assets 1.25b |
| B: -0.20 (Retained Earnings -244.3m / Total Assets 1.25b) |
| C: 0.05 (EBIT TTM 75.7m / Avg Total Assets 1.52b) |
| D: 0.86 (Book Value of Equity 575.2m / Total Liabilities 671.4m) |
| Altman-Z'' = 1.52 = BB |
| DSRI: 1.03 (Receivables 94.1m/76.9m, Revenue 819.4m/687.1m) |
| GMI: 1.19 (GM 26.09% / 21.99%) |
| AQI: 0.68 (AQ_t 0.34 / AQ_t-1 0.50) |
| SGI: 1.19 (Revenue 819.4m / 687.1m) |
| TATA: -0.17 (NI -63.2m - CFO 147.0m) / TA 1.25b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of July 07, 2026, the stock is trading at USD 11.81 with a total of 796,594 shares traded. Over the past week, the price has changed by -3.12%, over one month by -8.45%, over three months by -10.67% and over the past year by +36.37%.
Current recommended Stop Loss: 11.00 (which is 6.9% or 2.1 ATR below the current price).
Ecovyst has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy ECVT.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 15.9 | 34.6% |
P/E Trailing = 73.2353
P/E Forward = 20.0803
P/S = 1.7133
P/B = 2.3691
Revenue TTM = 819.4m USD
EBIT TTM = 75.7m USD
EBITDA TTM = 151.7m USD
Long Term Debt = 392.8m USD (from longTermDebt, last quarter)
Short Term Debt = 10.3m USD (from shortTermDebt, last quarter)
Debt = 446.4m USD (corrected: LT Debt 392.8m + ST Debt 10.3m) + Leases 43.3m
Net Debt = 283.8m USD (calculated: Debt 446.4m - CCE 162.6m)
Enterprise Value = 1.65b USD (1.36b + Debt 446.4m - CCE 162.6m)
Interest Coverage Ratio = 2.56 (Ebit TTM 75.7m / Interest Expense TTM 29.6m)
EV/FCF = 18.99x (Enterprise Value 1.65b / FCF TTM 86.7m)
FCF Yield = 5.27% (FCF TTM 86.7m / Enterprise Value 1.65b)
FCF Margin = 10.58% (FCF TTM 86.7m / Revenue TTM 819.4m)
Net Margin = -7.71% (Net Income TTM -63.2m / Revenue TTM 819.4m)
Gross Margin = 21.99% ((Revenue TTM 819.4m - Cost of Revenue TTM 639.3m) / Revenue TTM)
Gross Margin QoQ = 15.94% (prev 23.44%)
Tobins Q-Ratio = 1.32 (Enterprise Value 1.65b / Total Assets 1.25b)
Interest Expense / Debt = 6.63% (Interest Expense 29.6m / Debt 446.4m)
Taxrate = 38.45% (3.59m / 9.34m)
NOPAT = 46.6m (EBIT 75.7m * (1 - 38.45%))
Current Ratio = 2.38 (Total Current Assets 304.3m / Total Current Liabilities 127.9m)
Debt / Equity = 0.78 (Debt 446.4m / totalStockholderEquity, last quarter 575.2m)
Debt / EBITDA = 1.87 (Net Debt 283.8m / EBITDA 151.7m)
Debt / FCF = 3.27 (Net Debt 283.8m / FCF TTM 86.7m)
Total Stockholder Equity = 619.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.17% (Net Income -63.2m / Total Assets 1.25b)
RoE = -10.20% (Net Income TTM -63.2m / Total Stockholder Equity 619.7m)
RoCE = 7.48% (EBIT 75.7m / Capital Employed (Equity 619.7m + L.T.Debt 392.8m))
RoIC = 4.28% (NOPAT 46.6m / Invested Capital 1.09b)
WACC = 9.56% (E(1.36b)/V(1.81b) * Re(11.35%) + D(446.4m)/V(1.81b) * Rd(6.63%) * (1-Tc(0.38)))
Discount Rate = 11.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -2.07%
[DCF] Terminal Value 74.17% ; FCFF base≈71.1m ; Y1≈81.5m ; Y5≈120.0m
[DCF] Fair Price = 11.01 (EV 1.49b - Net Debt 283.8m = Equity 1.21b / Shares 109.5m; r=9.56% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -64.15 | EPS CAGR: -11.25% | SUE: 1.44 | # QB: 3
Revenue Correlation: 44.46 | Revenue CAGR: 2.67% | SUE: 3.09 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.19 | Chg30d=-1.62% | Revisions=+25% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.21 | Chg30d=-2.38% | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=0.66 | Chg30d=+1.25% | Revisions=+62% | GrowthEPS=+68.7% | GrowthRev=+34.7%
EPS next Year (2027-12-31): EPS=0.88 | Chg30d=+3.44% | Revisions=+57% | GrowthEPS=+33.6% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +77% (up=10, down=0)